Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Latanoprost (0.005% w/v) Eye Drop
Therapeutic Category
Ophthalmology
Dosage Form
Eye Drops
Packaging Type
Dropper
Packaging
5ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Latoshell Eye Drop (Latanoprost 0.005% w/v) is a premium, high-profit chronic care product built for our PCD Pharma Franchise partners.
Latanoprost is the most widely recognized and prescribed Prostaglandin Analogue, serving as the first-line therapy for reducing Intraocular Pressure (IOP) in patients with Open-Angle Glaucoma and Ocular Hypertension. Glaucoma is a lifelong, irreversible condition requiring daily, uninterrupted treatment.
Why Latoshell is Your Key to Profit:
Guaranteed Perpetual Revenue: Glaucoma treatment is mandatory and lifelong, ensuring stable, predictable, daily refills for the patient's entire lifetime and excellent financial stability for your franchise.
Maximum Specialty Margin: Positioned as the gold standard in the critical ophthalmic specialty segment, this product commands premium pricing and secures some of the highest profit margins in chronic eye care.
Superior Clinical Value: The once-daily dosing and potent efficacy of Latanoprost ensure superior patient compliance, which drives strong, reliable specialist loyalty and better outcomes.
Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition for this specific, essential glaucoma formulation. Partner with us for full marketing support to secure high-value, recurring prescriptions and guaranteed business growth.
Contact us today to capture this max-margin chronic specialty segment!
Common side effects may include transient burning or stinging upon instillation, redness, or itching of the eyes. Rarely, systemic effects or severe allergic reactions may occur.
Ketorine Eye Drop is indicated for the relief of pain and inflammation in the eyes following surgical procedures, as well as for treating allergic conjunctivitis and other inflammatory eye disorders.
For topical use only; do not ingest. Discontinue use and consult a healthcare professional if you experience severe irritation or an allergic reaction. Always follow your healthcare provider's instructions regarding dosage and application. Ketorine Eye Drop offers a targeted approach to managing ocular pain and inflammation, contributing to better patient outcomes and enhanced comfort during recovery. Always consult with a healthcare provider before starting any new medication.
Store at room temperature, away from direct sunlight. Keep the bottle tightly closed when not in use and out of reach of children.
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Composition : Paracetamol (100mg)
Composition : Diclofenac diethylamine (1.16% w/v) + Linseed Oil (3% w/v) + Methyl Salicylate (10% w/v) + Menthol (5% w/v)
Composition : Diclofenac diethylamine (1.16% w/w) + Thiocolchicoside (0.125% w/w) + Linseed Oil (3.0% w/w) + Methyl Salicylate (10.0% w/w) + Menthol (5.0% w/w)
Composition : Choline Salicylate (8.7% w/w) + Lidocaine (2.0% w/w) + Benzalkonium Chloride (0.01% w/w) Gel
Composition : Aceclofenac (100mg) + Paracetamol (325mg) + Cetirizine (10mg) + Phenylephrine (5mg) + Caffeine (25mg) Tablet
Composition : Aceclofenac (100mg) + Paracetamol (325mg) + Trypsin Chymotrypsin (50000AU)
Composition : Aceclofenac (100mg) + Paracetamol (325mg) + Serratiopeptidase (15mg) Tablet
Composition : Paracetamol (I.R.) 300mg + Paracetamol (S.R.) 700mg
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Latanoprost Eye Drops are used for the management of glaucoma and ocular hypertension by reducing intraocular pressure, making them a strong ophthalmology segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in ophthalmology clinics, eye hospitals, and chronic glaucoma management. As glaucoma requires long-term treatment, this product offers stable and recurring prescription demand.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for ophthalmic formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from long-term prescription demand, specialist ophthalmology usage, and repeat purchases associated with chronic glaucoma therapy when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this ophthalmic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.